Article
22 Apr 2025
Trump Administration Issues Executive Order To Lower Prescription Drug Costs
RANKINGS
This author falls within the Top 20% for their listed topics and industry categories. Based on Mondaq users readership, this author is ranked as VERY POPULAR in United States
AUTHORS CONTENT
Article
09 Oct 2024
September 2024 Medicaid Rebate Final Rule: Key Issues For Manufacturers
Article
11 Jul 2024
When APA Claims Accrue Under Corner Post: Implications For The Life Sciences Industry
Article
03 Jul 2024
Chevron Overturned: What Does It Mean For Life Sciences Companies?
Article
27 Oct 2023
FDA Updates Off-Label Communications Guidance
Article
22 Jul 2022
OIG Advisory Opinion On Continuing Education Provides Insight On Risk Areas
Video
02 May 2022
Arnold & Porter Life Sciences: Pharmaceutical Pricing & Contracting (Video)
Article
26 Jan 2022
HHS-OIG Rule Expands Opportunities For Advisory Opinions
Article
25 Nov 2021
Biden Administration Issues Rules Requiring Insurer Transparency On Drug Spending, Rebates And Fees: What Manufacturers Need To Know
Article
25 Nov 2020
Pharmacy Point-Of-Sale Price Concession And PBM Service Fee Safe Harbor Final Rule May Reshape Medicare Part D: What Pharmaceutical Manufacturers Need To Know Now